Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check3 days agoChange DetectedA new revision tag v3.5.4 has been added and the previous v3.5.3 tag removed. This represents a minor metadata update to the study record without changing its substantive content.SummaryDifference0.1%

- Check10 days agoChange DetectedNo additions or deletions are present in the analyzed changes payload for this page. This indicates that the page content has not been altered in the provided data.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s footer version label updates from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a minor site release without changing the study record content.SummaryDifference0.1%

- Check31 days agoChange DetectedThe revision label was updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedNo content additions or deletions were observed; the screenshots appear to show only cosmetic/UI layout differences.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. No study details or eligibility information appear to be changed.SummaryDifference0.1%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.